Clinical Trials Directory

Trials / Completed

CompletedNCT05672160

Overal Survival After TAVI According to Sarcopenia

CT Evaluated Sarcopenia Independently Predicts the Overal Survival After Transcatheter Aortic Valve Implantation

Status
Completed
Phase
Study type
Observational
Enrollment
930 (actual)
Sponsor
Nemocnice AGEL Trinec-Podlesi a.s. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to compare the overal survival after transcatheter aortic valve implantation (TAVI) according to sarcopenia status evaluated from preprocedural CT scans. The main question it aims to answer is: • Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

Detailed description

The patients suffering from aortic valve stenosis, that are not eligible for cardiosurgery were indicated to miniinvasive transcatheter aortic valve implantation (TAVI). The follow up of 930 patients were done in time interval from 1 to 11 years. In every patient the preprocedural CT scans were done. From these CT scans the L3 cross sections will be used for sarcopenia evaluation. Then we will statisticaly evaluate the overal survival after TAVI procedure in the relation with sarcopenia status. We will answer the main question: Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT evaluated sarcopeniaAt L3 level of CT scan we will measure the area and density of muscles and fat tissue. We devided the patients to sarcopenia and non-sarcopenia groups according to these values.

Timeline

Start date
2022-01-01
Primary completion
2023-01-01
Completion
2023-01-02
First posted
2023-01-05
Last updated
2023-01-05

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05672160. Inclusion in this directory is not an endorsement.